Market Overview

Physicians' Education Resource® Presents the 19th Annual International Lung Cancer Congress®


The meeting will present the latest data on novel therapies including
targeted agents, immunotherapy and multidisciplinary treatment strategies

Physicians' Education Resource® (PER®), the leading resource for
oncology and hematology continuing medical education, will host the 19th
annual International Lung Cancer Congress on July 26-28 at Hyatt Regency
Huntington Beach, California. The program will be chaired by David R.
Gandara, M.D.,
professor of medicine, division of
hematology/oncology, director, thoracic oncology program, senior advisor
to the director, University of California Comprehensive Cancer Center,
and Roy S. Herbst, M.D., Ph.D., Ensign professor of Medicine
(medical oncology), professor of pharmacology, chief of medical
oncology, associate director for translational research, Yale Cancer
Center, Yale School of Medicine.

"The field of lung cancer treatment is experiencing continuous
advancements," said Phil Talamo, president of PER®. "This meeting has
been a high-level collaborative ‘think tank' for nearly two decades,
allowing oncologists to network and collaborate on new agents and
strategies to enhance treatment for lung cancer."

The 19th annual International Lung Cancer Congress® is a
two-day event that shares current, practical information on novel agents
and strategies. Designed for surgical, medical and radiation oncologists
and other medical professionals interested in lung cancer, the meeting
includes engaging lectures, panel discussions and multidisciplinary
tumor boards. Attendees will gain insight into new strategies for early
detection of lung cancer, adjuvant therapy for non-small cell lung
cancer and bench-to-bedside concepts. Each day of the meeting will also
encompass post-session surveys and engaging question-and-answer sessions.

For more information and registration, visit

About PER®

Since 1995, Physicians' Education Resource, LLC® (PER®) has been the
leading provider of live and online continuing medical education
activities on oncology and hematology by providing high-quality,
evidence-based activities featuring leading experts who focus on the
application of practice-changing advances. In 2018, PER® will develop
and implement 20 historic annual legacy conferences in the United States
and Europe, along with many world-renowned online learning formats such
as Medical Crossfire®. PER® is accredited by both the Accreditation
Council for Continuing Medical Education and the California Board of
Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH
Associates, Inc. family of businesses. Learn more at and

View Comments and Join the Discussion!